ID

29762

Description

https://clinicaltrials.gov/show/NCT00197028 Non-serious adverse events and study conclusion Study ID: 103967 Clinical Study ID: 103967 Study Title: A Phase I/IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00197028 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: BIO MALARIA; SB257049 Study Indication: Malaria

Lien

https://clinicaltrials.gov/show/NCT00197028

Mots-clés

Versions (1)
  1. 18/04/2018 18/04/2018 -
Détendeur de droits

GlaxoSmithKline (GSK)

Téléchargé le

18 avril 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region, Study ID: 103967, NCT00197028

Anglais

Non-serious adverse events and study conclusion

1 Formulaires  
Non-serious adverse events
Description

Non-serious adverse events

Alias
UMLS CUI-1
C1518404
(Please report all serious adverse events only on the Serious Adverse Event (SAE) form). Has any non-serious adverse events occurred within one month (minimum 30 days) post vaccination, excluding those recorded on the Solicited Adverse Events pages?
Description

Non-serious adverse events

Type de données

text

Alias
UMLS CUI [1]
C1518404
AE No.
Description

AE No.

Type de données

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
Description
Description

Description

Type de données

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Site
Description

Site

Type de données

text

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
UMLS CUI [1,3]
C1518404
Date Started
Description

Date Started

Type de données

date

Alias
UMLS CUI [1]
C2697888
During immediate post-vaccination period (60 minutes)?
Description

Adverse event start

Type de données

boolean

Alias
UMLS CUI [1]
C2697888
Date stopped
Description

Date stopped

Type de données

date

Alias
UMLS CUI [1]
C2697886
Intensity
Description

Intensity

Type de données

integer

Alias
UMLS CUI [1]
C1710066
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship to investigational products

Type de données

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0439849
Outcome (at the interim analysis timepoint)
Description

Outcome

Type de données

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1518404
Study conclusion
Description

Study conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008976
UMLS CUI-3
C0042210
Did the subject experience any Serious Adverse Event during the study period?
Description

Serious adverse event

Type de données

boolean

Alias
UMLS CUI [1]
C1519255
If you answered the previous question with Yes → Specify total number of SAE's:
Description

Total number of SAE's

Type de données

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0449788
Was the treatment blind broken during the study?
Description

Treatment blind

Type de données

boolean

Alias
UMLS CUI [1,1]
C0749659
UMLS CUI [1,2]
C2347038
If you answered the previous question with Yes → Complete date and tick one reason below.
Description

Treatment blind broken date

Type de données

date

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0011008
If you answered the previous question with Yes Complete date and tick one reason below.
Description

Treatment blind broken reason

Type de données

integer

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C0392360
Did any elimination criteria become applicable during the study?
Description

Elimination criteria

Type de données

integer

Was the subject withdrawn from the study?
Description

Subject withdrawal

Type de données

boolean

Alias
UMLS CUI [1]
C0422727
If you answered the previous question with Yes → Please tick the ONE most appropriate category for withdrawal.
Description

Withdrawal reason

Type de données

integer

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008976
Please tick who took decision:
Description

Decision maker

Type de données

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0679006
Date of last contact:
Description

Date of last contact

Type de données

date

Alias
UMLS CUI [1]
C0805839
Was the subject in good condition at date of last contact?
Description

Condition at date of last contact

Type de données

text

Alias
UMLS CUI [1,1]
C0805839
UMLS CUI [1,2]
C1142435
UMLS CUI [1,3]
C0681850
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Description

Investigators signature

Type de données

text

Alias
UMLS CUI [1]
C2346576
Investigator signature date
Description

Investigator signature date

Type de données

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Printed Investigator's name:
Description

Printed Investigator's name

Type de données

text

Alias
UMLS CUI [1]
C2826892
Retour au début de la page

Similar models

Non-serious adverse events and study conclusion

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Non-serious adverse events
C1518404 (UMLS CUI-1)
Item
(Please report all serious adverse events only on the Serious Adverse Event (SAE) form). Has any non-serious adverse events occurred within one month (minimum 30 days) post vaccination, excluding those recorded on the Solicited Adverse Events pages?
text
C1518404 (UMLS CUI [1])
Non-serious adverse events
Code List
(Please report all serious adverse events only on the Serious Adverse Event (SAE) form). Has any non-serious adverse events occurred within one month (minimum 30 days) post vaccination, excluding those recorded on the Solicited Adverse Events pages?
CL Item
No (No)
CL Item
Yes, please complete the following table. (Yes, please complete the following table.)
AE No.
Item
AE No.
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Description
Item
Description
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Site
text
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
Site
Code List
Site
CL Item
[L] Administration site ([L] Administration site)
CL Item
[G] Non-administration site ([G] Non-administration site)
Date Started
Item
Date Started
date
C2697888 (UMLS CUI [1])
Adverse event start
Item
During immediate post-vaccination period (60 minutes)?
boolean
C2697888 (UMLS CUI [1])
Date stopped
Item
Date stopped
date
C2697886 (UMLS CUI [1])
Item
Intensity
integer
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity
CL Item
[1] Mild (1)
CL Item
[2] Moderate (2)
CL Item
[3] Severe (3)
Relationship to investigational products
Item
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C1518404 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Item
Outcome (at the interim analysis timepoint)
integer
C1705586 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Outcome
Code List
Outcome (at the interim analysis timepoint)
CL Item
[1] Recovered / Resolved (1)
CL Item
[2] Recovering / resolving (2)
CL Item
[3] Not recovered / not resolved (3)
CL Item
[4] Recovered with sequelae / Resolved with sequelae (4)
Item Group
Study conclusion
C1707478 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
Serious adverse event
Item
Did the subject experience any Serious Adverse Event during the study period?
boolean
C1519255 (UMLS CUI [1])
Total number of SAE's
Item
If you answered the previous question with Yes → Specify total number of SAE's:
integer
C1519255 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
Treatment blind
Item
Was the treatment blind broken during the study?
boolean
C0749659 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
Treatment blind broken date
Item
If you answered the previous question with Yes → Complete date and tick one reason below.
date
C3897431 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
If you answered the previous question with Yes Complete date and tick one reason below.
integer
C3897431 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Treatment blind broken reason
Code List
If you answered the previous question with Yes Complete date and tick one reason below.
CL Item
[1] Medical emergency requiring identification of investigational product for further treatments (1)
CL Item
[2] Other, specify: _______________________________________________ (2)
Item
Did any elimination criteria become applicable during the study?
integer
Elimination criteria
Code List
Did any elimination criteria become applicable during the study?
CL Item
No (1)
CL Item
Yes → Specify: __________________________________________________________ (2)
Subject withdrawal
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
If you answered the previous question with Yes → Please tick the ONE most appropriate category for withdrawal.
integer
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Withdrawal reason
Code List
If you answered the previous question with Yes → Please tick the ONE most appropriate category for withdrawal.
CL Item
[SAE] Serious adverse event (check Serious Adverse Event form) Please specify SAE N°: |__|__| (1)
CL Item
[AEX] Non-Serious adverse event (check the Non-serious Adverse Event section) Please specify unsolicited AE N°: |__|__| or solicited AE code: |__|__| (2)
CL Item
[PTV] Protocol violation, please specify: _______________________________________ (3)
CL Item
[CWS] Consent withdrawal, not due to an adverse event. (4)
CL Item
[MIG] Migrated / moved from the study area (5)
CL Item
[LFU] Lost to follow-up. (6)
CL Item
[OTH] Other, please specify: _________________________________________________ (7)
Item
Please tick who took decision:
integer
C0422727 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
Decision maker
Code List
Please tick who took decision:
CL Item
[I] Investigator (1)
CL Item
[P] Parents/Guardians (2)
Date of last contact
Item
Date of last contact:
date
C0805839 (UMLS CUI [1])
Item
Was the subject in good condition at date of last contact?
text
C0805839 (UMLS CUI [1,1])
C1142435 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
Condition at date of last contact
Code List
Was the subject in good condition at date of last contact?
CL Item
No, please give details within the Adverse Events section. (No, please give details within the Adverse Events section.)
CL Item
Yes (Yes)
Investigators signature
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
text
C2346576 (UMLS CUI [1])
Investigator signature date
Item
Investigator signature date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Printed Investigator's name
Item
Printed Investigator's name:
text
C2826892 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial